ANI Pharmaceuticals

Quarterly Financials

Values in thousands2025-09-302025-06-302025-03-312024-12-31
Revenue
$227,813
$211,371
$197,122
$190,574
Gross Profit
111,792
136,756
124,085
110,294
EBITDA
61,159
39,244
48,362
14,853
EBIT
38,527
15,963
25,471
-7,747
Net Income
24,134
8,549
15,681
-10,276
Net Change In Cash
227,813
211,371
197,122
190,574
Free Cash Flow
37,892
68,903
15,145
13,380
Cash
262,610
217,797
149,802
144,861
Basic Shares
21,093
20,308
20,046
19,445

Annual Financials

Values in thousands2024-12-312023-12-312022-12-312021-12-31
Revenue
$614,376
$486,816
$316,385
$216,136
Gross Profit
364,166
305,303
177,600
115,526
EBITDA
63,121
106,603
25,040
3,116
EBIT
-4,610
46,812
-34,613
-44,136
Net Income
-18,522
18,779
-47,896
-42,603
Net Change In Cash
614,376
486,816
316,385
216,136
Cost of Revenue
-52,067
92,434
Free Cash Flow
47,064
100,448
-47,658
-20,316
Cash
144,861
221,121
48,228
100,300
Basic Shares
19,318
18,194
16,260
12,596

Earnings Calls

QuarterEPS
2025-12-31
$0
2025-09-30
$2.04
2025-06-30
$0.36
2025-03-31
$0.69